Works matching AU MOON, MIN KYONG


Results: 87
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes (TRIPLE‐AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3642, doi. 10.1111/dom.15705
    By:
    • Kim, Nam Hoon;
    • Moon, Jun Sung;
    • Lee, Yong‐ho;
    • Cho, Ho Chan;
    • Kwak, Soo Heon;
    • Lim, Soo;
    • Moon, Min Kyong;
    • Kim, Dong‐Lim;
    • Kim, Tae Ho;
    • Ko, Eunvin;
    • Lee, Juneyoung;
    • Kim, Sin Gon
    Publication type:
    Article
    13
    14
    15
    17
    19
    20
    21
    22
    23
    24
    25
    26

    Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes.

    Published in:
    Journal of Diabetes Investigation, 2013, v. 4, n. 5, p. 466, doi. 10.1111/jdi.12074
    By:
    • Son, Jang Won;
    • Kim, Dong Jun;
    • Lee, Chang Beom;
    • Oh, Seungjoon;
    • Song, Kee‐Ho;
    • Jung, Chan Hee;
    • Mok, Ji Oh;
    • Kim, Jong Hwa;
    • Moon, Min Kyong;
    • Choi, Kyung Mook;
    • Cho, Jae Hyoung;
    • Choi, Sung Hee;
    • Kim, Soo Kyung;
    • Park, Kang Seo;
    • Kim, Hye Soon;
    • Kim, In Joo;
    • Kim, Young Il;
    • Kim, Hae Jin;
    • Kim, Sang Yong;
    • Kim, Sungrae
    Publication type:
    Article
    27

    A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)

    Published in:
    Journal of Diabetes Research, 2024, p. 1, doi. 10.1155/2024/8915591
    By:
    • Kim, Hae Jin;
    • Noh, Jung Hyun;
    • Moon, Min Kyong;
    • Choi, Sung Hee;
    • Ko, Seung-Hyun;
    • Rhee, Eun-Jung;
    • Hur, Kyu Yeon;
    • Jeong, In-Kyung
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    50

    Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial ( INICOM study).

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 87, doi. 10.1111/dom.12787
    By:
    • Lim, Soo;
    • Han, Kyung Ah;
    • Yu, JaeMyung;
    • Chamnan, Parinya;
    • Kim, Eun Sook;
    • Yoon, Kun‐Ho;
    • Kwon, Sam;
    • Moon, Min Kyong;
    • Lee, Kwan Woo;
    • Kim, Dong‐Jun;
    • Kim, Mikyung;
    • Wongtanate, Manaj;
    • Kim, Eun Young;
    • Kim, Sung‐Ho;
    • Lee, Moon‐Kyu
    Publication type:
    Article